Skip to content
value.today

Mediar Therapeutics, Inc.

Total raised
$128 M
3 rounds on record
Latest round
$38 M
Dec 2025
First round on record
Jan 2019
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Mediar Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2025$38 MNo. 3$10 to $50 million

Mediar Therapeutics, Inc.: Raise no. 3, Dec 2025

Investors in this round

18 investors had bought by the notice of Dec 23, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $76 M offered; $38 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rahul Ballal · Executive Officer, Director
  • Adam Cotton · Director
  • Allan Marchington · Director
  • Andreas Jurgeit · Director
  • Bharat Srinivasa · Director
  • Cassidy Blundell · Director
  • Maina Bhaman · Director
  • Marie-Claire Peakman · Director
  • Simon Sturge · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rahul Ballal, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 23, 2025. Read the notice at the SEC.

equitySEC
Nov 2022$85 MNo. 2$50 to $250 million

Mediar Therapeutics, Inc.: Raise no. 2, Nov 2022

Investors in this round

17 investors had bought by the notice of Oct 22, 2024: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$85 M of $85 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rahul Ballal · Executive Officer, Director
  • Andreas Jurgeit · Director
  • Anja Konig · Director
  • Cassidy Blundell · Director
  • Maina Bhaman · Director
  • Meredith Fisher · Director
  • Michael Baran · Director
  • Simon Sturge · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rahul Ballal, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Oct 22, 2024. Read the notice at the SEC.

equitySEC
Jan 2019$5 MNo. 1$2 to $10 million

Mediar Therapeutics, Inc.: Raise no. 1, Jan 2019

Investors in this round

7 investors had bought by the notice of Feb 6, 2019: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stacey Brenner · Executive Officer
  • Brian Hubbard · Director
  • David de Graaf · Director
  • Meredith Fisher · Director
  • Peter Parker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stacey Brenner, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 6, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Mediar Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2025).

    SEC Form D · Dec 2025

  • The industry group it chose in its notices: Other.

    SEC Form D · Dec 2025

That is all the official record says: Mediar Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Mediar Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 18 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Mediar Therapeutics, Inc.
NameRoleNamed in
Rahul BallalExecutive officerDec 2025
Meredith FisherExecutive officerDec 2022
Stacey BrennerExecutive officerFeb 2019
Adam CottonDirectorDec 2025
Allan MarchingtonDirectorDec 2025
Andreas JurgeitDirectorDec 2025
Bharat SrinivasaDirectorDec 2025
Cassidy BlundellDirectorDec 2025
Maina BhamanDirectorDec 2025
Marie-Claire PeakmanDirectorDec 2025
Rahul BallalDirectorDec 2025
Simon SturgeDirectorDec 2025
Anja KonigDirectorOct 2024
Meredith FisherDirectorOct 2024
Michael BaranDirectorOct 2024
Peter ParkerDirectorNov 2023
Nandita ShangariDirectorDec 2022
Brian HubbardDirectorFeb 2019
David de GraafDirectorFeb 2019